Research On Financial Performance Evaluation Of Chinese Medicine Industry Listed Company

During the implementation of the national "Twelfth Five Year Plan", the pharmaceutical industry has long been the strong support of the industry.The pharmaceutical industry by a variety of industrial structure, Chinese medicine industry is also an important component of the development of Chinese medicine industry is also optimistic about the industry’s prospects. But with some well-known international companies to push into the field of medicine, our Chinese enterprises are facing unprecedented challenges. Financial Performance Evaluation of Enterprise has been the topic of many scholars and business owners are concerned about and discussed, reasonable and effective financial performance evaluation system may appear insufficient business presence in the management process, the development of enterprise development and lay a good decision for managers to evaluate basis. For the 2013 running of the characteristics of traditional Chinese medicine industry, the paper of 53 selected Chinese listed companies as research objects constructed financial performance evaluation system based on the modified score of the Wall, on the financial performance of 53 Chinese listed companies score and draw rankings, combined with traditional Chinese medicine in 2014 earnings of listed companies, testing the effectiveness of the financial performance evaluation system. After that, select the medicine industry in Liaoning Fushun backbone strength with development potential, using established financial performance analysis system to analyze its financial performance levels.For the Chinese medicine industry listed companies’ financial performance levels, research article proceed from five chapters. The first chapter is an introduction, he introduced the background and significance of topics, review of researches on enterprise performance evaluation theory and methods, as well as research methods and ideas and innovations. The second chapter deals with a method of financial performance on financial performance evaluation theory and evaluation of this paper. The third chapter from six parts to evaluate the financial performance of Chinese listed companies. First, the overall operation of the Chinese industry starting in 2013, summed up the characteristics of today’s development of Chinese enterprises. Then 53 Chinese listed companies as an object, and establishing financial performance evaluation system development of Chinese Listed Companies. Finally, to verify the effectiveness of the financial performance evaluation system. The fourth chapter a case study, select the medicine in the middle level of listed companies as a case study of Liaoning Fushun object evaluation tools take strategic analysis and financial analysis are combined, a five-year longitudinal comparison of their own financial data and through its Other companies with Chinese industry horizontal comparison and found Jilinaodong in the course of business problems and propose countermeasures. The fifth chapter summarizes and concludes the paper, presented herein also need to improve the place.